Alerts will be sent to your verified email
Verify EmailINDOCO
Indoco Remedies
|
Zota Health Care
|
Novartis
|
|
---|---|---|---|
Operational Metrics
|
|||
API Sector
|
|||
US DMF Filings
|
26.0 . | n/a | n/a |
Global DMFs filed
|
147.0 . | n/a | n/a |
Pharmaceutical Sector
|
|||
Number of ANDA's Filed in USA
|
57.0 . | n/a | n/a |
Number of ANDA's Approved By USFDA
|
29.0 . | n/a | n/a |
Domestic Sales Growth - YoY
|
-4.3 % | n/a | -5.28 % |
R&D as a % of Total Sales
|
6.0 % | 0.09 % | n/a |
Financials
|
|||
5 yr Average ROE
|
11.09 % | -1.91 % | 5.71 % |
5yr average Equity Multiplier
|
1.79 | 1.71 | 2.57 |
5yr Average Asset Turnover Ratio
|
0.92 | 0.99 | 0.22 |
5yr Avg Net Profit Margin
|
6.73 % | -0.52 % | 11.91 % |
Price to Book
|
2.04 | 15.34 | 2.7 |
P/E
|
0.0 | 0.0 | 22.82 |
5yr Avg Cash Conversion Cycle
|
53.79 Days | 38.95 Days | -22.58 Days |
Inventory Days
|
66.59 Days | 94.16 Days | 44.4 Days |
Days Receivable
|
76.04 Days | 55.69 Days | 38.62 Days |
Days Payable
|
121.65 Days | 89.31 Days | 118.8 Days |
5yr Average Interest Coverage Ratio
|
7.97 | 18.17 | 32.45 |
5yr Avg ROCE
|
15.12 % | 1.25 % | 4.99 % |
5yr Avg Operating Profit Margin
|
15.97 % | 5.05 % | 10.55 % |
5 yr average Debt to Equity
|
0.38 | 0.03 | 0.0 |
5yr CAGR Net Profit
|
32.49 % | n/a | 53.24 % |
5yr Average Return on Assets
|
6.31 % | -0.16 % | 2.24 % |
Shareholdings
|
|||
Promoter Holding
|
58.9 % | 59.72 % | 70.68 % |
Share Pledged by Promoters
|
0.0 | 0.26 % | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.21 % | -8.39 % | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
1.0 % | 0.03 % | 0.0 |
Indoco Remedies
|
Zota Health Care
|
Novartis
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
-
|
-
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|